Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth Aetna InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
Health Commentaries
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools

InteliHealth Policies
Site Map
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Health News Health News
.
Associated Press

Auditors: Company's Records Not Enough To Link Ephedra To Heart Attacks
May 1, 2003

WASHINGTON (AP) -- Some 16,000 customer complaints about the popular Metabolife brand of ephedra are not enough to prove whether the herb caused dozens of heart attacks and strokes, some fatal, congressional investigators say.

The report released Wednesday doesn't mean ephedra is safe, the Food and Drug Administration stressed: There is evidence from other sources that the pills can cause serious health problems.

Armed with reports of more than 100 deaths and thousands of side effects linked to ephedra use, the FDA two months ago pledged to put warning labels on every bottle that say the amphetamine-like stimulant can cause heart attacks, strokes or even kill.

The General Accounting Office, Congress' investigative arm, examined 16,000 records of phone calls from ephedra customers with health complaints turned over to the Justice Department last year by Metabolife International.

The GAO counted 92 reports of serious side effects -- including 18 heart attacks, 26 strokes, 43 seizures and five deaths -- made by Metabolife customers to a company hot line.

The GAO concluded that there was far too little information to definitively link any of the reports to the pills because patients, not doctors, reported the problems, and Metabolife employees sometimes recorded just a single word from each phone call.

The FDA noted that the Rand Corp. also reviewed Metabolife's records, and called some of the cases "sentinel events" that warrant further investigation. Also, most of the agency's evidence is from other sources compiled before Metabolife revealed its records.

"Today's report does nothing to change FDA's heightened concern that dietary supplements containing ephedra may present a significant and unreasonable risk of illness and injury," the agency said.

Metabolife insisted the GAO report supports its position "that ephedrine-containing products such as Metabolife 356 are safe and effective when used as directed."

Rep. Dan Burton, who requested the report, said the GAO's findings show the government needs to establish a federal tracking system for consumer complaints about any dietary supplement.

The FDA decision came just weeks after Baltimore Orioles pitcher Steve Bechler died after using ephedra. Health and Human Services Secretary Tommy Thompson has advised Americans, especially those who exercise, not to take the herb.

The American Heart Association and other health groups have urged a full ban on ephedra sales, calls the FDA currently is evaluating.

Copyright 2003 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
Top News
General Health
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Eyes
Family Health
Fitness
Headache
Heart Health
HIV / AIDS
Infectious Diseases
Lung Cancer
Medications
Men's Health
Mental Health
Nutrition News
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.   HONcode
.
Chrome 2001
Chrome 2001